Blog Emily Bevis 12/07/2022 Emily Bevis 12/07/2022 mSAS® strategies for enabling simplified formulations Read More Emily Bevis 13/04/2022 Emily Bevis 13/04/2022 mSAS® strategies for enhanced intellectual property Read More Emily Bevis 18/02/2022 Emily Bevis 18/02/2022 Limiting the impact respiratory disease treatments have on the environment Read More Becky Murphy 09/02/2022 Becky Murphy 09/02/2022 mSAS® strategies for the development of natural products Read More Haleemah Amjid 23/12/2021 Haleemah Amjid 23/12/2021 Happy holidays from Crystec! Read More Becky Murphy 11/08/2021 Becky Murphy 11/08/2021 Developing biological drugs for inhaled delivery Read More Becky Murphy 21/04/2021 Becky Murphy 21/04/2021 mSAS® strategies for optimised inhaled delivery Read More Becky Murphy 09/02/2021 Becky Murphy 09/02/2021 mSAS® strategies for enhancing the stability of pharmaceutical products Read More Becky Murphy 20/01/2020 Becky Murphy 20/01/2020 mSAS® applications to progress your 2020 drug pipeline Read More Becky Murphy 06/12/2019 Becky Murphy 06/12/2019 mSAS® strategies for addressing poor drug solubility Read More Becky Murphy 25/08/2019 Becky Murphy 25/08/2019 Pharmaceutical Polymorphs Read More Becky Murphy 25/06/2019 Becky Murphy 25/06/2019 Factors influencing inhaled product development Read More LATEST NEWS
Emily Bevis 12/07/2022 Emily Bevis 12/07/2022 mSAS® strategies for enabling simplified formulations Read More
Emily Bevis 13/04/2022 Emily Bevis 13/04/2022 mSAS® strategies for enhanced intellectual property Read More
Emily Bevis 18/02/2022 Emily Bevis 18/02/2022 Limiting the impact respiratory disease treatments have on the environment Read More
Becky Murphy 09/02/2022 Becky Murphy 09/02/2022 mSAS® strategies for the development of natural products Read More
Becky Murphy 11/08/2021 Becky Murphy 11/08/2021 Developing biological drugs for inhaled delivery Read More
Becky Murphy 21/04/2021 Becky Murphy 21/04/2021 mSAS® strategies for optimised inhaled delivery Read More
Becky Murphy 09/02/2021 Becky Murphy 09/02/2021 mSAS® strategies for enhancing the stability of pharmaceutical products Read More
Becky Murphy 20/01/2020 Becky Murphy 20/01/2020 mSAS® applications to progress your 2020 drug pipeline Read More
Becky Murphy 06/12/2019 Becky Murphy 06/12/2019 mSAS® strategies for addressing poor drug solubility Read More
Becky Murphy 25/06/2019 Becky Murphy 25/06/2019 Factors influencing inhaled product development Read More
